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The Biosynthetic Gene Cluster for the -Lactam
Carbapenem Thienamycin in Streptomyces cattleya
sis, named imipenem, is the antibiotic of choice for clini-
cal use.
Biosynthesis of classic -lactam antibiotics (penicil-
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Departamento de Biologı´a Funcional and lins, cephalosporins, and cephamycins) is a well-known
process that takes place by condensation of L--Instituto Universitario de Oncologı´a
del Principado de Asturias aminoadipic acid, L-cysteine, and L-valine to form the
tripeptide -(L--aminoadipyl)-L-cysteinyl-D-valine (ACV)Universidad de Oviedo
33006 Oviedo by a nonribosomal peptide synthetase, named ACVS
(encoded by pcbAB genes). Cyclization of this tripeptideSpain
is then carried out by isopenicillin N synthase o IPNS
(encoded by pcbC gene). These two steps are common
to all producers of traditional -lactam antibiotics, both
Summary in bacteria and in fungi [3]. However, in the biosynthesis
of the nonclassic -lactam compounds (carbapenems
-lactam ring formation in carbapenem and clavam and clavams), a novel biosynthetic mechanism has been
biosynthesis proceeds through an alternative mecha- reported for the -lactam ring formation that involves
nism to the biosynthetic pathway of classic -lactam the biosynthetic enzyme, -lactam synthetase (-LS).
antibiotics. This involves the participation of a -lac- This enzyme was first reported to participate in the
tam synthetase. Using available information from biosynthesis of the simplest carbapenem antibiotic, car-
-lactam synthetases, we generated a probe for the bapen-2-em-3-carboxylic acid, produced by the phyto-
isolation of the thienamycin cluster from Streptomy- pathogen Erwinia carotovora (now Pectobacterium car-
ces cattleya. Genes homologous to carbapenem and otovorum), from which the gene cluster has been cloned
clavulanic acid biosynthetic genes have been identi- [4]. An equivalent mechanism, involving a -LS, was
fied. They would participate in early steps of thiena- shown to participate in the biosynthesis of the clavulanic
mycin biosynthesis leading to the formation of the acid, being its coding gene located within the gene clus-
-lactam ring. Other genes necessary for the biosyn- ter for this-lactamase inhibitor in Streptomyces clavuli-
thesis of thienamycin have also been identified in the gerus [5]. Both findings revealed the existence of an
cluster (methyltransferases, cysteinyl transferases, alternative pathway for the biosynthesis of carbapen-
oxidoreductases, hydroxylase, etc.) together with two ems and clavams.
regulatory genes, genes involved in exportation and/ Studies on the biochemistry of thienamycin biosyn-
or resistance, and a quorum sensing system. Involve- thesis have been addressed by Williamson et al. [6].
ment of the cluster in thienamycin biosynthesis was These authors provide biochemical evidence supporting
demonstrated by insertional inactivation of several that thienamycin biosynthesis in S. cattleya could pro-
genes generating thienamycin nonproducing mutants. ceed through an alternative pathway to that of cepha-
mycin C. According to these authors, the bicyclic ring
in thienamycin would derive from acetate (-lactam car-Introduction
bons) and glutamate (pyrroline ring), and they proposed
that it would be formed by condensation of acetyl-S-CoACarbapenems are a class of -lactam antibiotics with
with -glutamylphosphate instead of the ACV tripeptideimportant application as antimicrobial agents, particu-
formation as occurs in penicillins, cephalosporins, andlarly in infections mediated by multidrug-resistant bac-
cephamycins biosynthesis [6]. Li and coworkers [7, 8]teria. They show a broad spectrum of activity and are
reported the cloning of one gene (tcs) that was proposedrelatively resistant to most of the clinically encountered
to be involved in thienamycin biosynthesis. This genebacterial -lactamases. They are produced by Strepto-
product is a protein highly homologous to the C terminusmyces species, although they have also been identified
of ACVS, and they named it thienamycin cyclase. Imme-to be produced by gram-negative bacteria. Thienamycin
diately downstream of the tcs gene they also reported a(Figure 1) has been the first carbapenem isolated [1]. It is
pcbC-like gene encoding a protein resembling an IPNS.produced by Streptomyces cattleya NRRL 8057, which
Here we report the cloning of the thienamycin genealso synthesizes N-acetyl thienamycin and cephamycin
cluster from S. cattleya NRRL8057. We also report theC and penicillin N, and by Streptomyces penemifaciens.
sequencing and insertional inactivation of several genesThienamycin has been reported as the most potent of
of the cluster and the generation of different thienamycinthe naturally produced antibiotics, showing an extraor-
nonproducing mutants.dinary broad spectrum of activity, being highly resistant
to bacterial -lactamases [2], and playing an important
Resultsclinical role in the treatment of nosocomial infectious
diseases. However, thienamycin is highly unstable, and
Cloning of the Thienamycin Biosynthetic Gene Clustera most stable derivative produced by chemical synthe-
from Streptomyces cattleya NRRL8057
To clone the gene cluster for thienamycin biosynthesis
from S. cattleya NRRL8057 and based on the report of*Correspondence: jasalas@correo.uniovi.es
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used together with information from the related family
of class B asparagine synthetases (AS-Bs). These AS-
Bs show an overall sequence similarity to -LSs, despite
the fact that they catalyze very different reactions. To
construct the DNA probe for the screening, degenerate
oligoprimers were designed according to conserved
amino acid regions deduced from proteins alignment
between the two known-LSs:-LS from S. clavuligerus
[5] and CarA from P. carotovorum [4]. Amino acid re-
gions conserved in -LSs but not present in asparagine
Figure 1. Chemical Structure of Thienamycin
synthetases were clear candidates for the design of the
oligoprimers. Total genomic DNA from S. cattleya was
the cloning of a thienamycin cyclase gene tcs [7], we used as a template using the designed BLS1 and BLS4
used a cloning strategy by genetic homology. Two syn- oligoprimers, and after PCR amplification, a 233 bp DNA
thetic oligonucleotides were synthesized: LE1, including fragment was obtained that was cloned and sequenced.
the start codon of the tcs coding region, and LE4, corre- Analysis of the sequence revealed that the PCR product
sponding to a sequence within the downstream gene encoded an amino acid region similar to known -LS:
proposed to encode an IPNS by Li and coworkers [8]. 39% identity with -LS and 28% identity with CarA. We
Using these oligoprimers, we amplified a 559 bp frag- used this fragment as a probe for the screening of a
ment from S. cattleya genomic DNA that was cloned genomic library of S. cattleya. Three hybridizing cosmid
and sequenced. A BLAST search of the deduced prod- clones, cosCAT25, cosCAT22, and cosCAT14, showing
ucts from the amplified fragment showed similarities in overlapping restriction maps were isolated and one of
its 5 end with the tcs product, but with a degree of them, cosCAT25, selected for further analysis. Southern
identity (59% identity) much lower than expected. It also analysis (using the same probe) showed that at least
showed similarity to the pcbAB gene product, an ACVS two of the cosmids shared a hybridizing BamHI band
involved in cephamycin C biosynthesis (63% identity) of approximately 8.4 kb. To demonstrate the involve-
[9]. At its 3 end, the amplified fragment showed similari- ment of the cloned region in thienamycin biosynthesis,
ties with the first 28 amino acids of the pcbC-like gene two constructs were generated in a conjugative vector
product reported by Li et al. [8] and with the IPNS in- in which the aac(3)IV gene was inserted, in both orienta-
volved in cephamycin C biosynthesis (81% identity) [10]. tions, in the unique BglII site located in the middle of the
The PCR product was used as a probe against BamHI- 8.4 kb BamHI fragment. After intergeneric conjugation,
digested DNA from S. cattleya, and a 5 kb positively several mutants (apramycin resistant, thiostrepton sen-
hybridizing band was identified and cloned for further sitive) were obtained and analyzed by Southern hybrid-
analysis. To verify whether the cloned DNA region was ization and for thienamycin and cephamycin C produc-
involved in thienamycin biosynthesis, we carried out a tion by bioassay and HPLC. All these mutants were
gene replacement experiment. An apramycin resistance found to be nonproducers of thienamycin but still pro-
cassette containing the aac(3)IV gene was cloned into duced cephamycin C. Southern analysis also confirmed
the unique NcoI site located in the middle of the 5 kb the replacement of the 8.4 kb BamHI fragment of the
BamHI fragment. Then, the in vitro mutagenized frag- wild-type strain by a 9.9 kb BamHI fragment in all the
ment was subcloned into pHZ1358. Through interge- mutants. The results obtained with one of these mutants,
neric conjugation from E. coli ET12567 to S. cattleya T25N1, are shown in Figures 2 and 3. These experiments
and after a double crossover, the wild-type region was confirmed the involvement of this region in thienamycin
replaced by the in vitro mutated one. Transconjugants biosynthesis.
were selected for apramycin resistance and thiostrepton
sensitivity and verified by Southern hybridization, and
they were tested for -lactam production by HPLC and Sequence Analysis of the Thienamycin
Biosynthetic Gene Clusterby bioassay against Staphylococcus aureus ATCC
6538P (cephamycin C-resistant, thienamycin-sensitive The insert in cosCAT25, and two overlapping BamHI
fragments subcloned in pUC18 (pLE14 and pLE22) fromstrain) and Escherichia coli ESS (strain supersensitive
to -lactams). All of them were found to still produce cosCAT22 and cosCAT14, respectively, were sequenced.
The complete overlapping nucleotide sequence compris-thienamycin, but they did not produce cephamycin C
(data not shown). The conclusion from these experi- ing 32,329 bp was deposited at the EMBL Nucleotide
Sequence Database with accession number AJ421798.ments was that the use of the tcs gene as probe resulted
in the identification of the cephamycin C gene cluster Computer-assisted analysis of the DNA sequence re-
vealed the presence of 28 complete ORFs and two in-and not in the cloning of the thienamycin gene cluster.
Bearing in mind the report of a novel biosynthetic complete ones (Figure 4). Functions for 22 gene prod-
ucts in the biosynthesis of thienamycin were proposedmechanism involving the enzyme -lactam synthetase
(-LS) for the biosynthesis of a carbapenem [4] and after comparison of the deduced amino acid sequences
with other sequences in databases (Table 1). The prod-clavulanic acid [5] as an alternative to classic -lactam
antibiotic biosynthesis, we searched for the possible ucts of the other eight ORFs (designated as orf1–orf8)
did not show significant similarities with proteins in data-existence of an equivalent gene in the S. cattleya ge-
nome that could be involved in the biosynthesis of thie- bases, with the exception of orf5 that showed similarity
with a predicted phosphoesterase. Taking into consider-namycin. Available sequence information for -LSs was
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Figure 2. Insertional Inactivation in the Thie-
namycin Gene Cluster
(A) Scheme representing the replacement in
the chromosome of the wild-type thn region
by the in vitro mutagenized. “B,” BamHI; “G,”
BglII; “S,” SmaI. aac(3)IV, Am resistance
gene.
(B) Southern hybridization using the 8.4 kb
BamHI fragment as probe. Chromosomal
DNA from the wild-type strain and mutant
T25N1 were digested with BamHI and ana-
lyzed by Southern hybridization.
ation these data, we cannot propose a role for any of tion of the pyrroline ring [6]. In P. carotovorum it has
been shown that CarB would be responsible for thethese genes in thienamycin biosynthesis, although we
cannot exclude it. Some of the genes could be transla- first step in carbapenem biosynthesis [12, 13]. A BLAST
search with the thnE-deduced product showed signifi-tionally coupled with the stop codon of the first one
overlapping with the start codon of the second one. cant similarities with two enzymes catalyzing the first
step of carbapenem biosynthesis: CarB (37% identity)
from P. carotovorum [12] and the recently reportedGenes Probably Involved in Structural Functions
in Thienamycin Biosynthesis CpmB (33% identity) from Photorhabdus luminescens
[14]. ThnE shows a conserved region, which is commonIt has been reported that precursors of thienamycin and
carbapen-2-em-3-carboxylic acid derive from L-gluta- to the enoyl-CoA hydratase/isomerase (ECH) family of
enzymes which interact with acylCoA derivativesmate (pyrroline ring) and acetate (-lactam carbons) [6,
11]. In S. cattleya, it has been postulated that the initial (Pfam00378). We propose that ThnE could have an anal-
ogous function to CarB and CpmB, being responsiblereaction in thienamycin biosynthesis would be the con-
densation of acetyl-S-CoA with-glutamylphosphate (or for the condensation of glutamate and acetate as the
first step in thienamycin biosynthesis in S. cattleya lead-some other -activated form of glutamate) with forma-
Figure 3. HPLC Analysis of Cultures of Wild-
Type Strain and Mutant T25N1
HPLC analysis for cephamycin C (A and C)
and for thienamycin (B and D) production in
the wild-type strain (A and B) and in mutant
T25N1 (C and D). Detection was carried out
at 264 nm for cephamycin C and at 309 nm
for thienamycin. The arrows indicate the mo-
bility of cephamycin C (cef) and thienamycin
(thn).
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Figure 4. Genetic Organization of the thn Gene Cluster in S. cattleya
Proposed functions for the different genes are summarized in Table 1. The thn gene cluster is in blue. Sites for restriction enzymes are
abbreviated as follows: “B,” BamHI (all sites indicated); and “P,” PshAI; “S,” SnaBI; “G,” BglII; and “A,” BsaAI (only relevant sites for gene
replacement experiments are indicated for these four enzymes). Cosmid and plasmids from which the nucleotide sequence was obtained are
also shown.
ing to the formation of a biosynthetic intermediate con- vuligerus involved in clavulanic acid biosynthesis, 29%
identity [5], and CarA, involved in carbapenem biosyn-taining the pyrroline ring.
The deduced product of thnM showed significant sim- thesis in P. carotovorum, 25% identity [12]. All three
proteins, ThnM, CarA, and -LS, are related to membersilarities to -LSs involved in -lactam ring formation.
The closest homologs to ThnM were: -LS from S. cla- of the AS-Bs, ATP/Mg2-dependent amidotransferases
Table 1. Deduced Functions for the Genes in the Thienamycin Gene Cluster
Amino
Gene Acids Similar Protein (% Identity/Similarity), Accession Number Proposed Function
thnA 259 Putative oxidoreductase from Streptomyces coelicolor Reductase
(44/64), CAB58301
thnB 360 Putative regulator MmyR from Streptomyces coelicolor(29/52), Lactone-dependent
CAC36772 transcriptional regulator
thnC 212 Hypothetical efflux protein from Mesorhizobium loti Lactone efflux
(32/54), Np_104349 transmembrane protein
thnD 363 Probable zinc-binding dehydrogenase Yersinia pestis Oxidoreductase
(32/53), CAC90475
thnE 294 CarB from Erwinia carotovora (37/60), AAD38230 Condensation of acetyl-S-CoA
with -glutamylphosphate
thnF 327 N-acetyltransferase like protein Myxococcus xanthus N-acetyltransferase
(30/52), AAL56600
thnG 263 L-proline 4-hydroxylase from Dactylosporangium sp Hydroxylase
(29/49), BAA20094
thnH 224 Hypothetical protein from Thermobifida fusca Unknown
(42/59), ZP_00058519
thnI 476 claR protein from Streptomyces clavuligerus Transcriptional activator
(32/52), AAC38197
thnJ 483 Putative membrane transport protein from Streptomyces Transport protein
coelicolor (24/53), CAB92892
thnK 681 Fortimycin KL1 methyltransferase from Methyltransferase
Micromonospora olivasterospora (24/47),
BAA08420
thnL 474 Fortimycin KL1 methyltransferase fromMicromonospora Methyltransferase
olivasterospora(26/52), BAA08420
thnM 458 -ls from Streptomyces clavuligerus (29/53), AAC31901 -lactam synthetase
thnN 367 ORF2 from Streptomyces griseus(35/55), BAA37082 Unknown
thnO 472 ORF3 from Streptomyces griseus (30/50), BAA37083 Oxidoreductase
thnP 484 Phosphonoacetaldehyde methylase FOM3 from Methyltransferase
Streptomyces wedmoriensis(28/52), BAA32490
thnQ 259 Putative oxigenase AviO1 fromStreptomyces viridochromogenes Oxigenase
(34/54), AAK83181
thnR 240 Hypothetical protein from Streptomyces antibioticus Unknown
(43/65), AAL15612
thnS 329 ORF12 from Streptomyces clavuligerus -lactamase
(43/68), CAB03624
thnT 399 Hypothetical protein SCE22.10 from Streptomyces Cysteine transferase
coelicolor (71/81), CAB90977
thnU 268 Positive regulator CcaR from Streptomyces clavuligerus Transcriptional activator
(43/60), AAC32494
thnV 137 Glutathione transferase from Escherichia coli Cysteine transferase
(34/54), A60635
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Figure 5. Alignment of the Deduced Amino Acid Sequences of -LSs: -LS from S. clavuligerus, CarB from P. carotovorum, and ThnM from
S. cattleya
The arrows indicate the conserved regions selected for the oligonucleotides design for PCR amplification.
which catalyze the conversion of aspartic acid to aspar- SCE22.1 from Streptomyces coelicolor A3(2) (accession
number CAB90977), and it also shares a conserved do-agine. An alignment showing the conserved motifs
shared by the three -LS is shown in Figure 5. We pro- main in the amino acid region 80–124 and 297–383 char-
acteristic of the T4 peptidase family that include L- andpose that ThnM is a -LS with a role in -lactam ring
formation in thienamycin biosynthesis in S. cattleya. D-aminopeptidases, that can also act as transferases
(Pfam03576). ThnT could also play a role in the transferThienamycin contains a hydroxyethyl side chain that
derives from methionine through two methylations steps of the cysteine residue.
Several oxidoreduction steps are required for thiena-with retention of configuration as has been shown by
Floss and coworkers [15]. In the thienamycin gene clus- mycin biosynthesis. Several genes identified in the clus-
ter could encode oxidoreductases. The thnA-deducedter, three genes (thnK, thnL, and thnP) encode proteins
with significant similarities to methyltransferases from product showed significant similarities (44% identity,
accession number CAB58301) with a putative oxidore-different secondary metabolite gene clusters: 24%,
26%, and 25% identity for ThnK, ThnL, and ThnP, re- ductase from S. coelicolor. At the very beginning of
its amino-terminal region, ThnA contains a very well-spectively, with a methyltransferase involved in the bio-
synthesis of fortimicin [16] and with a methyltransferase conserved motif of the short chain dehydrogenases/
reductases (SDR) family. In the thienamycin biosyntheticinvolved in fosfomycin biosynthesis (20%, 24%, and
28% identity, respectively) [17]. Insertional inactivation pathway, ThnA could catalyze a reduction step between
C6 and C8 that would occur after the second methylationof thnL showed its involvement in thienamycin biosyn-
thesis (see below). We propose that some of these meth- step. The deduced product of thnD resembles a putative
zinc binding dehydrogenase (32% identity; accessionyltransferases could be responsible for the methylation
steps involved in the formation of the hydroxyethyl side number CAC90475). ThnD shows a well-conserved do-
main of zinc binding dehydrogenases. The gene productchain in thienamycin biosynthesis.
The thnV product showed significant similarity (34% of thnO displays a significant similarity with Orf3 from
Streptomyces griseus (30% identity; accession numberidentity) with a glutathione transferase from the fosfo-
mycin gene cluster [18]. In thienamycin biosynthesis, BAA37083) and with a probable aldehyde dehydroge-
nase from Acinetobacter sp. (25% identity) [19]. Genecysteine has been proposed as a precursor of the cys-
teaminyl side chain [6], and this transfer could be medi- replacement experiments showed the involvement of
ThnO in thienamycin biosynthesis (see below). We pro-ated by the ThnV protein. The product of another gene
(thnT) showed 71% identity with the hypothetical protein pose that ThnD and ThnO could catalyze two oxidation
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steps in thienamycin biosynthesis, occurring before and on the strong similarity of ThnI to ClaR, we propose for
ThnI a role as a regulatory protein, probably acting asafter the action of ThnA.
The closest similar protein to the thnG gene product a transcriptional activator of some thienamycin biosyn-
thetic genes in a similar way to ClaR in clavulanic acidis a L-proline 4-hydroxylase (29% identity) [20]. In the
thienamycin biosynthetic pathway, a hydroxylation re- biosynthesis.
The deduced product of thnU has been found to beaction could be one of the last steps in the biosynthesis
and ThnG could be responsible for this hydroxylation significantly similar (43% identity) to CcaR. CcaR is a
positive regulator which activates transcription of bothreaction.
clavulanic acid and cephamycin C biosynthetic genes
[27] and is related to the SARP family of regulatory pro-Genes Probably Involved in Exportation
teins [28]. ThnU shows a well-conserved bacterial tran-and/or Resistance
scriptional activator domain (BAD), found in the SARP-Several genes in the thienamycin cluster could be in-
like family of regulators. We propose for ThnU a functionvolved in secretion of the antibiotic and/or in conferring
in regulating early steps in thienamycin biosynthesis andresistance to the producer organism. The thnJ gene
probably cephamycin biosynthesis.product resembles the membrane transport protein
Two other genes in the cluster (thnB and thnC) are(32% identity; accession number CAB92892) from S.
probably involved in quorum-sensing regulation. ThnBcoelicolor A3(2) and the multidrug resistance protein
shows in its N-terminal region a well-conserved domainfrom Sulfolobus tokodaii (24% identity; accession num-
of bacterial regulatory proteins (Pfam00440) and dis-ber BAB66030). ThnJ showed a well-conserved N termi-
plays similarity to lactone-dependent transcriptionalnus region which is also found in the metabolite export
regulators such as MmyR (29%; accession numberpump, TcmA, involved in tetracenomycin C resistance
CAC36772) and MmfR (28%; accession number[21]. We propose for ThnJ a role in thienamycin secretion
CAC36768), two putative lactone-dependent transcrip-through the cell membrane in S. cattleya.
tional regulators (TetR family) from S. coelicolor [29].The thnF-deduced product showed a conserved do-
ThnC showed significant similarities with many putativemain present in the family of proteins with N-acetyl-
homoserine/homoserine lactone efflux transmembranetransferase (GNAT) functions, a family which includes
proteins, i.e., a protein from Mesorhizobium loti (32%acetyltransferases involved in antibiotic resistance
identity; accession number NP_104349). ThnC shares a(Pfam00583). The closest homolog is a N-acetyltrans-
well-conserved domain with the LysE type translocatorferase that acetylates a ribosomal protein (30% identity;
family (Pfam01810). It has been reported that synthesisaccession number AAL56600) and a putative acetyl-
of carbapenem-2-em-3-carboxilic acid is under quorumtransferase from S. coelicolor (26% identity; accession
sensing control [30]. In this bacterium, it has been shownnumber CAB59671). N-acetyl thienamycin has been de-
that the product of the first gene in the carbapenemtected in culture broths of S. cattleya together with thie-
cluster, named carR, is a member of the LuxR family ofnamycin, and a mutant strain of S. cattleya accumulating
transcriptional regulators which activates transcriptionN-acetyl-deshydroxythienamycin has also been isolated
of the remaining genes in the cluster in response to a[22]. The presence of an acetyltransferase in the clavu-
quorum-sensing signaling molecule, N-acyl homoserinelanic acid biosynthetic gene cluster with a putative role
lactone [31]. This homoserine lactone-dependent tran-in antibiotic resistance [23] has been recently reported.
scriptional activation allows the cells to coordinate ex-The closest homolog of the thnS gene product is ORF12
pression of carbapenem with cell density. In S. clavuli-from S. clavuligerus, (43% identity) that encodes a puta-
gerus, it has also been reported that clavulanic acidtive class A -lactamase [23, 24], and it also shows
and cephamycin C production are under cell-density-similarity to a putative secreted protein from S. coelico-
dependent control [32].lor (38% identity; accession number CAB52901). ThnS
shares a -lactamase-B motif which is conserved in the
metallo--lactamase superfamily (Pfam00753). Whether Genes with No Assigned Function
ThnS (and ThnF) are involved or not in thienamycin resis- There are few other genes (thnN, thnQ, thnH, and thnR)
tance has to be clarified. in the cluster for which a role in thienamycin biosynthesis
cannot be proposed based on the available information.
The closest homolog to the thnN-deduced product isGenes Probably Involved in Regulation
of Thienamycin Biosynthesis ORF2 from S. griseus (35% identity; accession number
BAA37082) of unknown function. ThnN, shows in its CThe thnI gene would encode a protein which shows the
highest similarity (32% identity) with the transcriptional terminus, significant similarity (26% identity) to RedM,
a putative peptide synthetase (accession numberactivator ClaR [25]. ClaR acts as an activator of clavu-
lanic acid biosynthesis. A disrupted mutant in claR accu- CAA16182) and contains a conserved domain of the
AMP binding enzymes. This family includes a number ofmulated clavaminic acid, suggesting for ClaR a role in
regulating late steps in clavulanic acid biosynthesis [26]. enzymes that catalyze reactions via an ATP-dependent
covalent binding of AMP to their substrates. InsertionalThnI and ClaR show two well-conserved domains: a
LysR-substrate binding domain and a helix-turn-helix inactivation of thnN has shown its involvement in thiena-
mycin biosynthesis (see below). The deduced productmotif of the LysR family. The latter motif is located at
the C terminus of the protein (like in the case of ClaR), of thnQ showed significant similarities with two proteins
involved in antibiotic biosynthesis: Avi01, an oxygenasewhich is in contrast with most of the LysR regulatory
proteins in which resides at the N terminus [26]. Based from the avilamycin cluster, 34% identity [33], and SnoK
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from the nogalamycin biosynthesis cluster, 30% identity treatment of nosocomial infectious diseases. At the time
we began our research on this cluster, there were only[34]. The deduced products of thnH and thnR showed
significant similarities with enzymes belonging to two two reports in the literature about the cloning of thiena-
mycin biosynthetic genes [7, 8]. These authors reporteddifferent hydrolases families. The closest homologs to
ThnH is a hypothetical protein from the actinomycete the cloning of the tcs gene, supposed to encode a cy-
clase involved in thienamycin biosynthesis. However,Thermobifida fusca (42% identity; accession number
ZP_00058519) of unknown function and a hydrolase as will be discussed below, the involvement of this gene
in thienamycin biosynthesis is questionable and re-from Caulobacter crescentus (30% identity; accession
number AAK22231). In its C-terminal region, ThnH quires reinterpretation.
Antibiotic biosynthetic gene clusters have beenshows part of a conserved domain of the hydrolase,
haloacid dehalogenase-like family. The deduced prod- cloned using different approaches. Two of the strategies
most commonly used are the cloning of resistanceuct of thnR is related to two proteins of unknown func-
tion from different Streptomyces species: 43% identity genes and the cloning by genetic homology. We could
not use the cloning of the resistance determinant andfor accession number AAL15612 and 42% identity for
accession number CAB45548. ThnR shows a conserved the search for biosynthetic genes in the adjacent DNA
due to the natural resistance of streptomycetes todomain characteristic of the NUDIX hydrolases family.
-lactams. Cloning by genetic homology using informa-
tion of previously characterized related pathways wasInsertional Inactivation in the Thienamycin
hampered in the case of thienamycin by the lack ofGene Cluster
appropriate probes. In fact, the use of the only availableTo demonstrate the involvement of different identified
probe, tcs gene, for the screening of genomic DNA fromgenes of the sequenced region in thienamycin biosyn-
S. cattleya, led us to the isolation of a chromosomalthesis, several mutants were generated by gene replace-
region that was found to be involved in cephamycin Cment. In all cases, the aac(3)IV gene was inserted within
biosynthesis as demonstrated by insertional inactiva-the coding region in the same direction of transcription
tion. Possibly these authors cloned cephamycin C bio-(and in the opposite one). After introduction of the con-
synthetic genes instead of thienamycin genes. In thestruct into S. cattleya by intergeneric conjugation, trans-
last years, a second major mechanism for -lactam ringconjugants in which a double crossover occurred were
formation has been reported for carbapenem and cla-identified by their resistance to apramycin and suscepti-
vam biosynthesis involving a -LS [4, 5]. Given the car-bility to thiostrepton and further verified by Southern
bapenem nature of thienamycin and assuming that aanalysis. The following genes were targeted: thnL, thnN,
similar process could be responsible for -lactam ringand thnO. In all three cases, the replacement gave rise
formation in thienamycin biosynthesis, we used con-to thienamycin nonproducing mutants, thus demonstra-
served regions between two known -LSs in the designting their involvement in thienamycin biosynthesis.
of degenerated oligonucleotides for PCR amplificationTwo other mutants were also generated at both ends
of part of a -LS-encoding gene from the S. cattleyaof the sequenced region in order to define the possible
genome. This approach by genetic homology resulted inboundaries of the thienamycin cluster. In one of the
the successful isolation of the thienamycin gene cluster.mutants, a single gene (orf2) located at the left end
The gene cluster for thienamycin biosynthesis wasof the sequenced region was mutated by inserting the
located in a region of approximately 26.5 kb in which 22aac3(IV) gene. In the second mutant, a gene replacement
genes were identified putatively involved in thienamycinwas carried out causing the simultaneous deletion of
biosynthesis. Gene replacement experiments of somefour orfs (orf4–orf7) and partial deletion of other two
of the genes in the cluster generated thienamycin non-(orf3 and orf8) located at the right end of the sequenced
producing mutants as an unequivocal proof of theregion. The deduced products of all these orfs did not
involvement of the cloned cluster in the biosynthesis ofresemble any protein in databases that could indicate
this carbapenem.a possible role in thienamycin biosynthesis, although
Studies on the biochemistry of the biosynthetic path-we cannot exclude it. Both mutants still retained the
way for thienamycin have been reported [6, 15]. Weability to produce thienamycin at similar yields than the
have correlated the biochemical information from thesewild-type strain.
authors with our genetic data in an attempt to assign
functions to the gene products corresponding to partic-
Discussion ular biosynthetic steps. A temptative pathway for thiena-
mycin biosynthesis, essentially based on that proposed
Gene clusters for the biosynthesis of classic -lactam by Williamson et al. is shown in Figure 6. Earlier reactions
antibiotics have been isolated from different producers, in thienamycin biosynthesis are involved in formation of
both bacteria and fungi. In all the cases, the mechanism the bicyclic ring system. The initial reaction in thiena-
for -lactam ring formation involves two conserved mycin biosynthesis would be the pyrroline ring formation
steps: condensation of three aminoacids (L--amino- after condensation of acetyl-S-CoA with an activated
adipic acid, L-cysteine, and L-valine) by a nonribosomal form of glutamate. This reaction could be carried out by
peptide synthetase (ACVS) and cyclization of the formed then, since it shows similarity to CarB, the first enzyme in
tripeptide by an isopenicillin N synthase (IPNS). How- the biosynthesis of the simplest carbapenem molecule
ever, not much genetic information exists on the biosyn- in P. carotovorum, which is involved in condensation of
thesis of the carbapenem-type -lactam thienamycin, the precursors (acetate and glutamate).
Concerning the origins of the hydroxyethyl side chaindespite its significance and clinical importance in the
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One of the main features in thienamycin biosynthesis,
that occurs immediately after the first methylation step,
concerns the mechanism for -lactam ring formation
which involves a -LS that originates the typical bicyclic
ring structure of thienamycin. ThnM would be involved
in this step since it shows convincing similarity to -LSs
known to participate in carbapenem and clavulanic acid
biosynthesis [4, 5]. Once the bicyclic ring is formed, the
following step would be the generation of the cysteami-
nyl side chain through the transfer of a cysteine residue,
which could be carried out by the action of ThnV and/
or ThnT. Other gene products, ThnD and ThnO, could
be responsible for the oxidation reactions that occur
between carbons C6 and C8 before the second methyla-
tion step or later on between carbons C2 and C3. This
later oxidation step (C2, C3) takes place after a reduction
reaction, between carbons C6 and C8, probably cata-
lyzed by the action of ThnA, and it is not clear if it would
occur before or after a hydroxylation reaction, putatively
carried out by ThnG, and would render thienamycin as
a final product.
Genes encoding proteins probably involved in expor-
tation and/or resistance have been also found in the
cluster. ThnJ, resembles membrane transport proteins,
and we propose that it would play a role in thienamycin
secretion through the cell membrane. In addition, ThnF,
a putative N-acetyltransferase highly related to acetyl-
transferases involved in antibiotic resistance, would be
responsible for the formation of N-acetyl thienamycin
that has been also found in culture broths of S. cattleya.
It has been suggested that N-acetyl thienamycin could
be the last intermediate of the thienamycin pathway in
S. cattleya, and this would be consistent with a possible
role in resistance. Another protein, ThnS, could repre-
sent a type A -lactamase, with a role not yet clarified
in thienamycin biosynthesis and/or resistance. These
type of enzymes have been identified in -lactam pro-
ducers (mainly cephamycin producers) and also in non-
producing actinomycetes. They are cell wall-bound ex-
tracellular enzymes, and it is discussed whether they
Figure 6. Proposed Biosynthetic Pathway for Thienamycin Biosyn-
are involved in antibiotic resistance, in modulation ofthesis in S. cattleya and Assignment of Functions to the Different
antibiotic biosynthesis, or in cell-wall formation [3].Genes
Many pathway-specific transcriptional regulators in-The biosynthetic pathway is based on that proposed by Williamson
volved in the production of different antibiotics haveet al. [6].
been found among antibiotic-producing actinomycetes,
and in most cases they regulate expression of all biosyn-of thienamycin, it has been shown that the hydroxyethyl
thetic and resistance genes in the cluster. Two excep-side chain derives from methionine through two single
tions are ClaR, which only regulates the expression ofcarbon transfers with two methyl group incorporations
genes involved in late steps of the biosynthesis (afterinvolving S-adenosylmethionine [15]. In accordance
clavaminic acid) of clavulanic acid [26], and CcaR, in-with that, it has been reported that, in addition to thiena-
volved in regulation of the early steps (up to clavaminicmycin, S. cattleya also produces northienamycin, which
acid) of the same cluster [27]. In addition, CcaR is in-contains a single carbon side chain at C-6 instead of the
volved in regulation of a second gene cluster, cepha-two carbons side chain of thienamycin [35]. According to
mycin C [27]. Two genes of the thienamycin cluster, thnIWilliamson et al. [6], the first methylation step in thiena-
and thnU, encode transcriptional activators similar tomycin biosynthesis would take place immediately after
ClaR and CcaR, and possibly would act in a similarthe condensation of precursors and before -lactam
manner to these two activators. Thus, some of the genering formation, but the second methylation step would
products of the thienamycin cluster have their homolo-occur later in the pathway once the bicyclic ring was
gous counterparts in the carbapenem or clavam clus-formed (Figure 6). Three genes in the thienamycin clus-
ters, which is consistent with the relatedness found be-ter, thnK, thnL, and thnP, would encode proteins with
tween the biosynthesis of these two -lactam groups.significant similarities to methyltransferases from differ-
Two other gene products found in the thienamycinent secondary metabolite gene clusters and could cata-
lyze these methylation reactions. cluster could belong to a quorum-sensing regulation
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For sporulation, S. cattleya was cultured on Bennet medium andsystem. ThnB is a putative lactone-dependent transcrip-
for antibiotic production in R5A medium [37] using an inoculumtional regulator, and ThnC shows similarity to putative
previously grown in TSB medium (Merck). When needed, antibioticshomoserine lactone efflux transmembrane proteins. In
were added to a final concentration of 25 g/ml for thiostrepton,
S. cattleya, some mutants deficient in the synthesis of apramycin, kanamycin, chloramphenicol, or nalidixic acid; 100 g/
a diffusible factor required for thienamycin biosynthesis ml for ampicillin; and 20 g/ml for tobramycin. pUC18 (Pharmacia)
and the pUC derivative pIJ2925 [38] were used as E. coli cloninghave been isolated, and thienamycin production was
vectors. Cosmid pKC505 [39] was used for construction of the geno-restored in one of these mutants after feeding with a
mic library and cosmid pHZ1358 [40] for intergeneric conjugation.diffusible product from another mutant [36]. These au-
thors suggested a role for this diffusible product in regu-
DNA Manipulation
lating expression of the thienamycin cluster in a similar Total DNA isolation, plasmid DNA preparations, restriction endonu-
way to homoserine lactone regulating carbapenem pro- clease digestions, ligations, and other DNA manipulations were per-
duction in the nondifferentiating bacterium P. caroto- formed according to standard procedures for E. coli [41] and for
Streptomyces [42]. S. cattleya genomic library was constructed invorum. In thienamycin biosynthesis, ThnB and ThnC
cosmid pKC505. Intergeneric conjugation from E. coli ET12567could play a similar role in an analogous quorum sensing
(pUB307) into S. cattleya was done using procedures previouslyregulation system.
described [43]. Total genomic DNA from S. cattleya was used as
The availability of the genes for thienamycin biosyn- template for polymerase chain reaction (PCR) to obtain two indepen-
thesis provides the potentiality of its use for increasing dent probes, tcs and -ls, that were used for the screening of either
thienamycin yields through heterologous expression of the chromosomal DNA or the cosmid library, respectively. For tcs
amplification the following oligoprimers were used: LE1 (5-ATCGTCthe cluster in another suitable host or through the use
TAGAATGCGGCTGGCCCGAGGGGGAGAAGATCGACAA-3, XbaIof the regulatory and/or structural genes. Furthermore,
underlined) and LE4 (5-ATCGAAGCTTCGCCTGGGCGTCGGGTCGit opens up the possibility of generating by combinatorial
GTGCCGAACAACTG-3, HindIII underlined). For -ls-like amplifica-
biosynthesis novel derivatives with improved therapeu- tion, the following degenerated oligoprimers were used: BLS1
tic properties, biosynthetic intermediates for further (5-ATCGTCTAG ACG/C GAG/C ACG/C TCG/C AAC GAG TTG/C-3,
chemical modification, or derivatives with better stability XbaI underlined) and BLS4 (5-ATCGAAGCTT G/CGA G/CCC CTC
GTG GAC GCC-3, HindIII underlined). PCR reactions were carriedproperties.
out in a total volume of 50 l, and the mixture contained 0.1 g of
S. cattleya total DNA, 30 pmol of each oligonucleotide primer (for tcs
Significance amplification), and 200 pmol of each degenerated oligonucleotide
primer (for -ls amplification), dNTPs (final concentration of 200
The biosynthetic gene cluster for the therapeutically M), 1PCR buffer from Taq DNA polymerase, and 5 U of Taq
DNA polymerase (GIBCO-BRL). Reactions were performed on a MJimportant -lactam antibiotic thienamycin has been
Research MiniCycler with the following program: 1 cycle of denatur-cloned and characterized from the producer organism
ation at 98	C (5 min), 30 cycles of denaturation/annealing/synthesisStreptomyces cattleya. According to the deduced
at 94	C (1 min)/65	C (1 min)/72	C (1 min), and 1 cycle of final exten-
functions of the different gene products, biosynthesis sion at 72	C (5 min). DNA fragments obtained after PCR amplification
of thienamycin should proceed through an alternative were cloned in the E. coli vector pUC18 and subjected to DNA
mechanism to that of classic -lactam antibiotics sequencing. Labeling of DNA probes were performed with -32P-
dCTP or with digoxigenin, and Southern analysis, hybridization, and(pencillins, cephalosporins, and cephamycins). This
detection were performed according to literature procedures [41] andmechanism involves the participation of a -lactam
manufacturer recommendations (Amersham, Boehringer Mannheim).synthetase as occurs in the biosynthesis of a simple
carbapenem by Pectobacterium carotovorum and cla-
DNA Sequencing
vulanic acid by Streptomyces clavuligerus. Knowledge DNA sequencing was performed on double-stranded DNA tem-
of the thienamycin gene cluster will allow the estab- plates by using the dideoxynucleotide chain termination method
lishment and understanding of the biosynthesis of this and the Cy5 Autocycle Sequencing Kit (Pharmacia Biotech). An
ALF-express automatic DNA sequencer (Pharmacia) was used toclinically important antibiotic. It will also provide a
sequence both DNA strands with primers supplied in the kit or withgreat potential for increasing thienamycin production
internal oligoprimers (17-mer). Computer-aided database searchingthrough the use of pathway-specific regulatory genes
and sequence analyses were made using the GCG sequence analy-
in the producer strain or through the heterologous sis software package of the University of Wisconsin Genetics Com-
expression of the cluster in another host. Genetic ma- puter group and the BLAST program.
nipulation also opens up the possibility of generating
Gene Replacement Experimentsnovel thienamycin derivatives with improved desirable
As a general rule, gene replacement experiments were carried outproperties for clinical use or for further chemical modi-
by insertion of the aac(3)IV gene. Introduction of plasmid DNA intofications. This could be achieved either by inactivating
S. cattleya was achieved through intergeneric conjugation from Esche-specific genes of the cluster in the producer organism
richia coli ET12567 harboring pUB307 as has been described [43].
or by combinatorial biosynthesis with genes from For insertional inactivation of the tcs-like region, a 1.5 kb BamHI
other related -lactam antibiotic producers. (blunt-ended)-SmaI containing the aac(3)IV gene was cloned in both
orientations into the unique NcoI (blunt-ended) site located in the
middle of the 5 kb BamHI fragment previously cloned in pUC18 toExperimental Procedures
generate pLE5AF and pLE5AR. Then, the in vitro mutagenized
BamHI fragments were subcloned into pHZ1358 generating plas-Bacterial Strains, Culture Conditions, and Vectors
Streptomyces cattleya NRRL8057 was used in this study. E. coli mids pHZLE5F and pHZLE5R (depending on the fragment orien-
tation).DH10B (GIBCO) was used as a cloning host, E. coli ED8767 for
constructing the cosmid library, and E. coli ET12567 (pUB307) for For generation of a mutant in the thnN coding region, a 8.4 kb DNA
BamHI fragment cosCAT25 was subcloned into pUC18, resulting inintergeneric conjugation. Staphylococcus aureus ATCC 6538P, tie-
namycin sensitive-cephamycin C-resistant strain, and E. coli ESS, pLESC6. The aac(3)IV gene was then inserted as a BamHI (blunt-
ended)-SmaI fragment in the BglII site (blunt-ended) located withina supersensitive strain to all -lactams, were used for bioassays.
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thnN, generating pLE6F and pLE6R. The resultant 9.9 kb BamHI of bacterial carbapenem antibiotic production genes reveals a
novel beta-lactam biosynthesis pathway. Mol. Microbiol. 22,inserts were excised and subcloned into pHZ1358 generating
pHZLE6F and pHZLE6R. 415–426.
5. Bachmann, B.O., Li, R., and Townsend, C.A. (1998). -LactamFor insertional inactivation of thnL, a construct was generated by
subcloning a 8.5 kb BglII fragment into pIJ2925, resulting in pLESC4. synthetase: a new biosynthetic enzyme. Proc. Natl. Acad. Sci.
USA 95, 9082–9086.The aac(3)IV gene was then inserted as a BamHI (blunt-ended)-
SmaI fragment in the SnaBI site located within thnL generating 6. Williamson, J.M., Inamine, E., Wilson, K.E., Douglas, A.W.,
Liesch, J.M., and Albers-Scho¨nberg, G. (1985). Biosynthesis ofpLE4F and pLE4R. The resultant 10 kb BglII inserts were excised
and subcloned into pHZ1358 generating pHZLE4F and pHZLE4R. the -lactam antibiotic, thienamycin, by Streptomyces cattleya.
J. Biol. Chem. 260, 4637–4647.To obtain a mutant in thnO, we used the previously generated
pLESC6 (see above) in which the aac(3)IV gene was inserted as a 7. Li, R., Wang, Y., and Zeng, Y. (1993). Cloning of thienamycin
biosynthetic genes from Streptomyces cattleya. Chin. J. Bio-BamHI (blunt-ended)-SmaI fragment in the PshAI site located within
thnO, generating pLE7F and pLE7R. The resultant 9.9 kb BglII inserts tech. 9, 1–7.
8. Li, R., and Wang, Y. (1996). Gene localization and expressionwere excised and subcloned into pHZ1358 generating pHZLE7F
and pHZLE7R. of thienamycin cyclase gene in Streptomyces lividans TK24.
Chin. J. Biotech. 12, 1–7.For insertional inactivation of ORF2, the corresponding 4.8 kb
BamHI fragment was subcloned in pUC18 resulting in pLE14. The 9. Coque, J.J., Martin, J.F., Calzada, J.G., and Liras, P. (1991).
The cephamycin biosynthetic genes pcbAB, encoding a largeaac(3)IV was then inserted as a BamHI (blunt-ended)-SmaI fragment
in the PshAI site generating pLE2F and pLE2R. The 6.3 kb BamHI multidomain peptide synthetase, and pcbC of Nocardia lac-
tamdurans are clustered together in an organization differentinserts were subcloned in pHZ1358 giving rise to pHZLE2F and
pHZLE2R. from the same genes in Acremonium chrysogenum and Penicil-
lium chrysogenum. Mol. Microbiol. 5, 1125–1133.For the generation of a deletion mutant lacking ORFs 4–7 and
part of ORFs 3 and 8, the corresponding 6.1 kb BamHI fragment 10. Loke, P., Ng, C.P., and Sim, T.S. (2000). PCR cloning, heterolo-
gous expression, and characterization of isopenicillin N syn-was subcloned into pUC18 resulting in pLE22. Then, the four internal
BsaAI fragments were replaced by the aac(3)IV gene causing a thase from Streptomyces lipmanii NRRL 3584. Can. J. Microbiol.
46, 166–170.deletion in ORFs 3 to 8. The aac(3)IV gene was inserted in this
construct as a BamHI-HindIII blunt-ended fragment in the BsaAI 11. Bycroft, B.W., and Maslen, C. (1988). The biosynthetic implica-
tions of acetate and glutamate incorporation into (3R,5R)-carba-generating pLE
3-8F and pLE
3-8R, from which the resultant 4.2
kb inserts were obtained and subcloned into pHZ1358 generating penem-3-carboxylic acid and (5R)-carbapen-2-em-3-carboxylic
acid by Serratia sp. J. Antibiot. 4, 1231–1242.pHZLE
3-8F and pHZLE
3-8R.
12. McGowan, S.J., Sebaihia, M., O’Leary, S., Hardie, K.R., Williams,
P., Stewart, G.S.A.B., Bycroft, B.W., and Salmond, G.P. (1997).Analysis of -Lactam Production
Analysis of the carbapenem gene cluster of Erwinia carotovora:Thienamycin and Cephamycin C production was qualitatively as-
definition of the antibiotic biosynthetic genes and evidence forsayed by bioassay using the thienamycin-sensitive strain Staphylo-
a novel beta-lactam resistance mechanism. Mol. Microbiol. 26,coccus aureus ATCC 6538P (cephamycin C resistant) and E. coli
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13. Li, R., Stapon, A., Blanchfield, J.T., and Townsend, C.A. (2000).tion and quantitative analysis of thienamycin and cephamycin C
Three unsusual reactions mediate carbapenem and carba-production was performed by HPLC using a reverse phase column
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